MeadowBrook Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$912K Hold
3,590
0.72% 37
2026
Q1
$878K Sell
3,590
-30
-0.8% -$6.99K 0.78% 36
2025
Q4
$749K Sell
3,620
-25
-0.7% -$4.94K 0.64% 41
2025
Q3
$676K Sell
3,645
-231
-6% -$39.6K 0.58% 44
2025
Q2
$592K Sell
3,876
-50
-1% -$7.69K 0.53% 46
2025
Q1
$651K Sell
3,926
-650
-14% -$102K 0.61% 40
2024
Q4
$662K Sell
4,576
-35
-0.8% -$5.42K 0.59% 39
2024
Q3
$747K Sell
4,611
-387
-8% -$61.7K 0.67% 39
2024
Q2
$731K Sell
4,998
-2,928
-37% -$435K 0.69% 39
2024
Q1
$1.25M Sell
7,926
-175
-2% -$27.9K 1.17% 24
2023
Q4
$1.27M Buy
+8,101
New +$1.24M 1.21% 21

Other funds holding JNJ

MeadowBrook Investment Advisors's JNJ Position: Q2 2026 in Review

MeadowBrook Investment Advisors held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 3,590 shares worth $912K. The position accounts for 0.72% of the portfolio, ranked #37.

MeadowBrook Investment Advisors first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.27M in Q4 2023. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • MeadowBrook Investment Advisors held 3,590 shares of Johnson & Johnson worth $912K as of Q2 2026.
  • MeadowBrook Investment Advisors left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.72% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #37 holding.
  • MeadowBrook Investment Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • MeadowBrook Investment Advisors's Johnson & Johnson position peaked at $1.27M in Q4 2023.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.